Argenx Se ARGX
NASDAQ ARGX
$962.22 +16.40 (+1.73%)
At close: Sep 24, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Long-Term Investments (2020 - 2026)

Argenx Se's (ARGX) quarterly Long-Term Investments came in at -$4.0 million in Q2 2026, down 100.04% on a YoY basis from $10.7 billion in Q2 2025, and down 100.12% quarter-over-quarter from $3.4 billion in Q4 2025.

Analysis

Argenx Se (ARGX) Long-Term Investments (2020 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Long-Term Investments for 7 consecutive years, with -$4.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Long-Term Investments fell 100.04% year-over-year to -$4.0 million; the trailing twelve-month figure through Jun 2026 stood at -$4.0 million (down 100.04% YoY), and the FY2025 full-year result was $3.4 billion, down 63.55% from the prior year.
  • Long-Term Investments slipped to -$4.0 million in Q2 2026 per ARGX's latest filing, from $3.4 billion in the prior quarter.
  • Across five years, Long-Term Investments topped out at $10.7 billion in Q2 2025 and bottomed at -$4.0 million in Q2 2026.
  • Historically, Long-Term Investments has averaged $3.1 billion across 5 years, with a median of $667.7 million in 2022.
  • The sharpest annual moves came in 2025 and 2026: Long-Term Investments surged 161757.86% in 2025, then tumbled 100.04% in 2026.
  • Over 5 years, Long-Term Investments stood at $1.3 billion in 2022, then tumbled by 99.25% to $9.9 million in 2023, then soared by 93402.82% to $9.3 billion in 2024, then sank by 63.55% to $3.4 billion in 2025, then plunged by 100.12% to -$4.0 million in 2026.
  • According to Business Quant data, Long-Term Investments over the past three periods registered -$4.0 million, $3.4 billion, and $10.7 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn -
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 266.00 Mn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 297.00 Mn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn -
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 5.79 Bn
10 Argenx Se 58.53 Bn 53.35 Bn 1.37 Bn -4.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.00 Mn
Dec 31, 2025 3.38 Bn
Jun 30, 2025 10.68 Bn
Dec 31, 2024 9.27 Bn
Jun 30, 2024 6.60 Mn
Dec 31, 2023 9.91 Mn
Jun 30, 2023 12.44 Mn
Dec 31, 2022 1.32 Bn
Jun 30, 2021 100.56 Mn
Dec 31, 2020 6.31 Mn
API Access

Argenx Se Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=ARGX&period=max&api_key=YOUR_API_KEY